España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Zevra Therapeutics
ZVRA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$8.97
0
0.00%
Pre-Market: 4:00 PM EDT
Get Report
Comment
Zevra Therapeutics (ZVRA) Forecast
News
Earnings
Zevra Therapeutics (ZVRA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Zevra Therapeutics (NASDAQ:ZVRA) Stock
Zevra Therapeutics Stock (NASDAQ: ZVRA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 20, 2024
HC Wainwright & Co. Reiterates Buy on Zevra T...
Benzinga Newsdesk
Thursday, November 14, 2024
Canaccord Genuity Maintains Buy on Zevra Ther...
Benzinga Newsdesk
Tuesday, November 12, 2024
Zevra Therapeutics Q3 2024 GAAP EPS $(0.69) M...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, November 11, 2024
Zevra Therapeutics To Present Relevant Data O...
Benzinga Newsdesk
Friday, October 11, 2024
Cantor Fitzgerald Reiterates Overweight on Ze...
Benzinga Newsdesk
Wednesday, October 09, 2024
NUCDF and Zevra Therapeutics Launch Check Amm...
Benzinga Newsdesk
Monday, October 07, 2024
Zevra Therapeutics shares are trading higher ...
Benzinga Newsdesk
Guggenheim Initiates Coverage On Zevra Therap...
Benzinga Newsdesk
Tuesday, October 01, 2024
Cantor Fitzgerald Reiterates Overweight on Ze...
Benzinga Newsdesk
Monday, September 30, 2024
HC Wainwright & Co. Reiterates Buy on Zevra T...
Benzinga Newsdesk
Tuesday, September 24, 2024
Beyond The Numbers: 7 Analysts Discuss Zevra Therapeutics Stock
Benzinga Insights
Zevra Therapeutics shares are trading higher ...
Benzinga Newsdesk
JMP Securities Initiates Coverage On Zevra Th...
Benzinga Newsdesk
Maxim Group Maintains Buy on Zevra Therapeuti...
Benzinga Newsdesk
Roth MKM Maintains Buy on Zevra Therapeutics,...
Benzinga Newsdesk
Zevra Therapeutics Says It Will Present Top-L...
Nabaparna Bhattacharya
Monday, September 23, 2024
XOMA Royalty Says Zevra Therapeutics Received...
Benzinga Newsdesk
Friday, September 20, 2024
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
Vandana Singh
HC Wainwright & Co. Maintains Buy on Zevra Th...
Benzinga Newsdesk
Zevra Therapeutics Shares Resume Trade
Benzinga Newsdesk
Trading Halt: Halt status updated at 12:35:00...
Benzinga Newsdesk
Zevra Therapeutics Presents New Data For Arim...
Benzinga Newsdesk
Wednesday, September 18, 2024
Canaccord Genuity Maintains Buy on Zevra Ther...
Benzinga Newsdesk
Friday, September 06, 2024
Zevra Therapeutics Presents Five Posters At S...
Benzinga Newsdesk
Monday, August 19, 2024
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Thursday, August 15, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Wednesday, August 14, 2024
Zevra Therapeutics shares are trading higher ...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Ze...
Benzinga Newsdesk
Tuesday, August 13, 2024
Zevra Therapeutics Mixed Q2 Results: Details
Erica Kollmann
Zevra Therapeutics Q2 2024 GAAP EPS $(0.48) M...
Benzinga Newsdesk
Friday, August 09, 2024
PubMatic, Eventbrite, Five9 And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
Zevra Therapeutics Prices $60M Public Offerin...
Benzinga Newsdesk
Thursday, August 08, 2024
ZVRA Therapeutics shares are trading lower af...
Benzinga Newsdesk
Zevra Therapeutics Announces Proposed Public ...
Benzinga Newsdesk
Monday, August 05, 2024
Cantor Fitzgerald Reiterates Overweight on Ze...
Benzinga Newsdesk
Why Kellanova Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
FDA Panel Backs Zevra's Arimoclomol For Rare Genetic Disorder, Analyst Highlights Balanced Portfolio Of Marketed Products And Pipeline Assets Focused On Rare Diseases
Vandana Singh
HC Wainwright & Co. Maintains Buy on Zevra Th...
Benzinga Newsdesk
Reported Friday, Zevra Therapeutics Gains FDA...
Benzinga Newsdesk
Friday, August 02, 2024
Trading Halt: Halt status updated at 6:15:00 ...
Benzinga Newsdesk
Trading Halt: Halted at 6:55:00 a.m. ET - Tra...
Benzinga Newsdesk
Tuesday, July 23, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Thursday, July 18, 2024
Insiders Buying Zevra Therapeutics And 1 Other Stock
Avi Kapoor
Wednesday, July 17, 2024
Insiders Buying Barnes & Noble Education And 2 Other Stocks
Avi Kapoor
Thursday, July 11, 2024
Zevra Rises on Update on Niemann-Pick Disease Type C Drug
Zacks
Tuesday, July 09, 2024
FDA Convenes Expert Panel Meeting For Zevra Therapeutics' Arimoclomol, Analyst Optimistic About Approval Despite Small Patient Base
Vandana Singh
HC Wainwright & Co. Reiterates Buy on Zevra T...
Benzinga Newsdesk
Zevra Announces The U.S. FDA Has Indicated Th...
Benzinga Newsdesk
Tuesday, June 18, 2024
Zevra Therapeutics Selects Orsini As The Spec...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch